about
The Chromatin Signature of Pluripotency: Establishment and MaintenanceEpigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based ModelsRole of extracellular RNA-carrying vesicles in cell differentiation and reprogrammingInduction of pluripotency by defined factorsReprogramming cells with synthetic proteinsThe Oct4 protein: more than a magic stemness markerShared mechanisms in stemness and carcinogenesis: lessons from oncogenic virusesThe extended pluripotency protein interactome and its links to reprogrammingThe Role of microRNAs in Stemness of Cancer Stem CellsTranscription factor-mediated reprogramming toward hematopoietic stem cellsThe "virgin birth", polyploidy, and the origin of cancerFrom "directed differentiation" to "neuronal induction": modeling neuropsychiatric diseaseResearch Progress of PR Domain Zinc Finger Protein 14The reverse control of irreversible biological processesCombined Overexpression of JARID2, PRDM14, ESRRB, and SALL4A Dramatically Improves Efficiency and Kinetics of Reprogramming to Induced Pluripotent Stem Cells.Bmi1 Is a Key Epigenetic Barrier to Direct Cardiac Reprogramming.Solving the puzzle of Parkinson's disease using induced pluripotent stem cells.Large-scale mapping of mammalian transcriptomes identifies conserved genes associated with different cell states.Reprogramming the cardiac fieldCell state plasticity, stem cells, EMT, and the generation of intra-tumoral heterogeneity.Transient induction of ING4 by Myc drives prostate epithelial cell differentiation and its disruption drives prostate tumorigenesis.Mechanisms for enhancing cellular reprogrammingProneural transcription factor Atoh1 drives highly efficient differentiation of human pluripotent stem cells into dopaminergic neuronsC/EBPα creates elite cells for iPSC reprogramming by upregulating Klf4 and increasing the levels of Lsd1 and Brd4.The developmental potential of iPSCs is greatly influenced by reprogramming factor selectionIdentification of a gene expression driven progression pathway in myxoid liposarcoma.Biophysical regulation of epigenetic state and cell reprogramming.p53: the barrier to cancer stem cell formation.De novo formation of insulin-producing "neo-β cell islets" from intestinal crypts.Concise Review: Reprogramming, Behind the Scenes: Noncanonical Neural Stem Cell Signaling Pathways Reveal New, Unseen Regulators of Tissue Plasticity With Therapeutic Implications.Models of human core transcriptional regulatory circuitries.In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming.The dyskerin ribonucleoprotein complex as an OCT4/SOX2 coactivator in embryonic stem cells.RNA-binding proteins in pluripotency, differentiation, and reprogramming.X chromosome reactivation dynamics reveal stages of reprogramming to pluripotencySmall molecules facilitate rapid and synchronous iPSC generation.Collaborative rewiring of the pluripotency network by chromatin and signalling modulating pathwaysSingle cell analysis reveals the stochastic phase of reprogramming to pluripotency is an ordered probabilistic process.Novel insights into embryonic stem cell self-renewal revealed through comparative human and mouse systems biology networksRetinoic Acid Induces Embryonic Stem Cell Differentiation by Altering Both Encoding RNA and microRNA Expression
P2860
Q26740030-10268554-E342-4519-8E85-1D87665F4889Q26772307-65540D6F-5813-434D-8AC7-1ACC0C01F3ACQ26786205-04C74A18-BFB2-480A-90FD-2979813FC7AAQ26830425-7D3F30A1-5746-4618-91E7-0D86F943D579Q26853155-A37E9B0F-4E1B-41DA-AF43-F37CF1A2BA1CQ26862078-C31AEF1F-00A1-4E3B-BE9F-DA9B553F28CDQ26863339-0D64C50E-079E-4CF1-A0C4-303B149A4190Q27003212-6E5B18EE-9B94-4BC0-A52C-0208ECA062B4Q27005618-1617FAB0-07AA-4C86-8A0D-5B70CA95C407Q27023005-FF7D1C80-E747-4FF3-B4D8-5E5B4B02AADDQ27024916-8C511838-F278-4B02-869C-C7835C38944DQ27692698-CC6A166D-3635-4731-87FA-3DC3CA788470Q28072146-D9573B25-A78B-4CB5-9908-F3D83E288310Q28077193-21890B9D-DFFD-4E05-8BB8-4D9FECDB4F71Q29465547-607CC78F-1BBD-4AF9-AF1A-8482D7358670Q30724300-D04FE8CA-C9CF-4392-8707-D789147591F3Q33358637-66C989C5-A83E-45A7-99CC-45EF1C54C9E2Q33557481-79975538-6095-471A-9713-FE878EDBBB1AQ33716314-C3752C80-9317-403C-BB84-9FF707ABE068Q33767473-FFFFC293-1C14-4676-8521-C86D58578DBFQ33789808-FBBECF29-BE3F-4D69-B7EA-ABF539305A09Q33943321-714DB587-7060-405A-BAD6-18111619B3D4Q33975612-D8504AC0-BC39-476A-99C5-160FCC249D8AQ34046454-89F79FCD-6307-4BA8-AC67-BC0001695FD0Q34222768-B4EB4E9A-6C21-4142-8FB5-95A5766D686EQ34227540-65C7B568-9316-4BDA-B018-0BB13D8EAE08Q34378901-410230D5-720C-484D-BAFE-8C25E9D44316Q34406072-9B4E4048-AFCC-4239-8B61-06AE755D96E3Q34409239-2D429109-27AD-437A-B005-404710C890EDQ34494195-FAEEFB90-EAAD-43EA-8C31-18B103D5144CQ34512262-9A7E5EAD-2170-4DE4-A066-C1E53558EA49Q34547502-78808BBE-5DD9-4AEA-A295-189BEB7BA60DQ34729447-28839206-E54A-4D38-B805-D79350403567Q34788864-AE1D22F7-4B44-48FB-A047-6E2DF920AC97Q34803951-62A2696A-8255-45F5-A61C-E3E171000C58Q35078302-C6098F8D-DA7C-4AFD-A0D9-DAE4B960AF6BQ35139931-0B1AE583-646B-4939-8B1B-5FB16F78D2D0Q35152234-5F8858D0-8253-4C61-8EBE-DB88F42859FEQ35500571-FE64F928-70E7-43B9-97D7-809B0A9DD094Q35688315-594FD3EE-809E-4546-9767-1FBC7C4D3E98
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Mechanisms and models of somatic cell reprogramming.
@ast
Mechanisms and models of somatic cell reprogramming.
@en
Mechanisms and models of somatic cell reprogramming.
@nl
type
label
Mechanisms and models of somatic cell reprogramming.
@ast
Mechanisms and models of somatic cell reprogramming.
@en
Mechanisms and models of somatic cell reprogramming.
@nl
prefLabel
Mechanisms and models of somatic cell reprogramming.
@ast
Mechanisms and models of somatic cell reprogramming.
@en
Mechanisms and models of somatic cell reprogramming.
@nl
P2860
P356
P1476
Mechanisms and models of somatic cell reprogramming.
@en
P2093
Dina A Faddah
Yosef Buganim
P2860
P2888
P304
P356
10.1038/NRG3473
P577
2013-06-01T00:00:00Z
P5875
P6179
1006015627